Vanda Pharmaceuticals (VNDA) Change in Inventory (2012 - 2026)

Vanda Pharmaceuticals has reported Change in Inventory for 14 years, with the latest figure at -$294000.0 in Q1 2026.

• Quarterly Change in Inventory fell 115.89% year-over-year to -$294000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 30.71% YoY) and the FY2025 annual result came in at $3.5 million, up 11851.72% from the prior year.
• Change in Inventory slipped to -$294000.0 in Q1 2026 per VNDA's latest filing, from $1.3 million in the prior quarter.
• Over five years, Change in Inventory peaked at $1.8 million in Q1 2025 and troughed at -$294000.0 in Q1 2026.
• A 5-year average of $497117.6 and a median of $368000.0 in 2025 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2025: Change in Inventory slumped 133.75% in 2023, then jumped 6479.31% in 2025.
• Over 5 years, Change in Inventory stood at $1.1 million in 2022, then tumbled by 62.21% to $427000.0 in 2023, then slumped by 74.94% to $107000.0 in 2024, then jumped by 1096.26% to $1.3 million in 2025, then slumped by 122.97% to -$294000.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$294000.0, $1.3 million, and -$32000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.